Oragenics Inc (OGEN)

Sidoti Events, LLC's May Micro-Cap Virtual ConferenceMay 20, 2026 7:30 AM
ACCESS NewswireNEW YORK, NY / ACCESS Newswire / May 20, 2026 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day May Micro-Cap Virtual Investor Conference taking place Wednesday and Thursday, May 20-21, 2026. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links. Presentation Schedule*All Times EDTWednesday, May 20, 2026 (Day 1)8:30-9:00Huize Holding Limited (HUIZ)*****9:15-9:45U Power Limited (UCAR)SuperCom (SPCB)10:00-10:30InTest Corporation (INTT)Dyadic Applied BioSolutions (DYAI)10:45-11:15International Battery Metals (IBATF)A2Z Cust2mate (AZ)11:30-12:00C1 Fund (CFND)Oil States International (OIS)12:15-12:45Heliostar Metals (HSTR)Acme United Corporation (ACU)1:00-1:30Matrix Service Company (MTRX)Horizon Aircraft (HOVR)1:45-2:15Intrusion Inc. (INTZ) 2:30-3:00ESS Tech (GWH)*****3:15-3:4520/20 Biolabs, Inc. (AIDX)*****4:00-4:30***** 1x1s Only(20th)Bassett Furniture (BSET)****************All Times EDTThursday, May 21, 2026 (Day 2)8:30-9:00Owlting Group (OWLS)Einride (LEGT)9:15-9:45Mastech Digital, Inc. (MHH)CBAK Energy Technology (CBAT)10:00-10:30Cabbacis (CABI)Electra AI (IRHO)10:45-11:15Intellicheck (IDN)*****11:30-12:00Harvard Bioscience, Inc. (HBIO)Stakeholder Gold Corporation (SRC)12:15-12:45*****First Phosphate (FRSPF)1:00-1:30SafeSpace Global Corp. (SSGC)*****1:45-2:15Myomo, Inc (MYO)*****2:30-3:00Flexsteel Industries, Inc. (FLXS)*****3:15-3:45Oragenics, Inc. (OGEN)Power Metallic Mines (PNPNF)4:00-4:30Highland Copper Company (HDRSF)*****1x1s Only(21st)Bassett Furniture (BSET)***************About Sidoti Events, LLC ("Events") and Sidoti & Company, LLC ("Sidoti")
In 2023, Sidoti & Company, LLC formed an affiliate company, Sidoti Events, LLC in order to focus exclusively on its rapidly growing conference business and to more directly serve the needs of presenters and attendees. The relationship allows Events to draw on the over 25 years of experience Sidoti has as a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti's coverage universe comprises approximately 130 equities, of which over 80 percent participate in the firm's rapidly growing Company Sponsored Research ("CSR") program. Events is a leading provider of corporate access through the many investor conferences it hosts each year. By virtue of its direct ties to Sidoti, Events benefits from Sidoti's small- and microcap-focused nationwide sales force, which has connections with over 2,500 institutional relationships in North America. This enables Events to provide multiple forums for meaningful interaction for small and microcap issuers and investors specifically interested in companies in the sector.Media Contact:Ally Cecil
Conference Coordiantor

Needs volume

https://investorshub.advfn.com/stock-market/AMEX/oragenics-OGEN/trades
No burst baskets yet but watching closely because it just hit zero borrow ,vol is 50% above 10 day average

HALTED $$$$$$$$%$$$

Odyssey Health, Inc selling approx 17k shrs...have 715k shrs left post rs....could be tax reasons?...imao...r

Was a big mover this morning. I about 130K shares and am now $2.5K down. This may be my Big Beautiful Loss of the year,

From latest 10q and with $4mil in financing since... "The Company believes its working capital at September 30, 2024 will be sufficient to meet the business objectives as presently structured only through the fourth quarter of 2024. As such, there is substantial doubt that we can continue as a going concern beyond that date."...they burn thru $2.5-$3mil per quarter now b4 the trial starts...something gotta give...i'm not a hater by any means...imao..r

Obviously the 10k said something about needing more capital
What else is new clinical stage med tech land

Sooner or later they will need to do a RS…just a question if b4 or after the start of phase 2a trial announcement…running out of time to get over a buck … and they need funding if you read the 10k…imao…r

OGEN new 52/week low

OGEN: I lost--my-shirt today, behind this catastrophic 'fire storm' event!! (Can Trump please do a FLY-OVER to assess the damage --- and then otherwise do a Federal-Bailout for ME???!!!)

How did this not get halted today. Obvious P & D

They got me me fortunately only put 700 in it.  So dumb to chase these turds

Well Trump is here to help Day Traders. This could get ugly.

OGEN: I'm ashamed to admit this, but I grabbed $3K worth of this at $0.57 in the Pre-Market today --- totally abandoning my standard practice of seeing if it 'HAS ANY LEGS' in the Open-Market today. (To paraphrase one of the Orion's Board's legendary Founding Fathers --- 'Monk', or 'Augusta'??)

I'm PRAYING hard right now --- see ME below, live --- for circa $1.50 here, a little later today. (Heck, whatever WORKS --- right??)

OGEN..................................https://stockcharts.com/h-sc/ui?s=OGEN&p=W&b=5&g=0&id=p86431144783

OGEN: Unusual PR here ---
https://finance.yahoo.com/news/oragenics-inc-chief-medical-officer-131500235.html

Obviously, they are trying to exploit & capitalize upon the NFL fears of BRAIN injuries:

"advancing innovative treatments for concussion and brain-related health conditions"

OGEN: Hot-off-the-PRESS!!! What kind of news is this???!!!

"Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Participate in the 12th Annual Brain Health Summit at the Leigh Steinberg Super Bowl Party 2025"

OGEN: And all behind NOT DUMPING MORE SHARES, purported "news".

The best premarket runner .59 + 107%

OGEN: See its Post-M 'CHART', below!!

And all behind the following Ages-Old TRICK, to desperately get your Firm's stock PRICE to go UP for once!!
"DJ Oragenics Withdraws Filing for a Securities Offering"

I have various scans set up to alert me…🥳

Curious as to how would've you been alerted to this when at 4:00`, it closed at .325 down .01 ?

Who's excited...🥳...its just a flip...

Don't get too excited, purely a manipulation (hence aftermarket) by Dawson James to do a financing, I'm sure you'll see the 8k tomorrow or Friday. JMHO

OGEN...58s clearing on volume...🥳

OGEN 10Q due 11/11

Dilution at 55 cents. Sell.

Oragenics Inc. ($OGEN) is a healthcare innovator focusing on novel antibiotics and treatments for oral mucositis. With a 52-week range of $0.86 to $7.74, it is advancing products like OG716, LBPs, and Terra CoV-2 immunization.

WOW more weak hands. And with only 5.6 mil os :)

The average one-year price target for Oragenics, Inc. is $91.80. :)

Weak many hands are gone, new investors welcome. :)

Weak many hands are gone, new investors welcome. :)

Not for long. :)

OGEN under $2

OGEN under $2

OGEN 10Q due 3/19

China Dump

News just hit! Oragenics Issues Update to Shareholders:
https://www.otcmarkets.com/stock/OGEN/news/story?e&id=2676834

OGEN steady rise looks like this biotech is ready to run!

Will this turd float to the surface? :)

Maybe not. :)

Don't madder they will short it down to nothing

Surfs up. ::)

Chart setup perfectly here -> time is koming for the super spike

https://stockcharts.com/h-sc/ui?s=ogen

Hey whatever it takes to see it rise to the moon but wow hats off to your sacrifice. :)

,,,,,,,I’m out

3/22 Oragenics Initiates a Pivotal IND-Enabling Toxicology Study on its Intranasal COVID-19 Vaccine Candidate, NT-CoV2-1

"“We are thrilled to have begun this pivotal study with Frontage, a premier drug development contract research organization, and are thankful to the acceleration Frontage has offered our important IND-enabling study. We believe the results from this rabbit toxicology study will support our development strategy for our intranasal COVID-19 vaccine candidate, NT-CoV2-1. The intranasal delivery route is particularly relevant as it may further reduce transmission of the virus and provide a needle-free delivery option. The findings from this preclinical toxicology study will be a part of our Investigational New Drug filing to the U.S. Food and Drug Administration,” said Frederick W. Telling, Ph.D., Executive Chairman of Oragenics."


https://ir.oragenics.com/press-releases/detail/142

KABOOM !! ve got movement!!

Looks like word is getting out. :)